Specialists Are Working on a HIV Cure

STATES CHRONICLE – Researchers have discovered a potential HIV cure after testing a combination of drugs on monkeys. This medication helped specialists overcome a version of HIV developing on monkeys. Scientists have used this treatment to cure monkeys’ HIV, and after two years of tests they found out the results of the study. They are hopeful when considering finding an HIV cure that could help so many people. The drugs which were tested on monkeys are called antiretroviral therapy and is also known as ART.

Besides these drugs, they have also been using an experimental antibiotic which was meant to attack the same target as Takeda Pharmaceutical’s Entyvio. Takeda was used to treating Chron’s illness and ulcerative colitis, being authorized in over fifty countries. This new study was published on October 11. The results which were displayed determined the scientists working at the National Institutes of Health to immediately begun evaluating the Takeda treatment.

This drug is also known as vedolizumab and scientists are trustful when imaging its results after treating HIV patients. Dr. Anthony Fauci, who is the director of the National Institute of Allergy and Infectious diseases and has also taken part in the study, has argued that this experimental drug managed to boost the immune system of the HIV-infected monkeys. It also determined the achievement of rehabilitation, by stopping the dangerous virus from developing.

The stage of sustained remission of the disease means that the cure has worked in treating monkeys. Scientists are confident that this drug will combat the HIV which infected human cells and attacked the immune system. A set of effective treatments that make use of the antiretroviral therapy have demonstrated to give spectacular results. This medicine determined a significant drop of the dangerous virus in the drop vessels.

Aftab Ansari, who co-lead the study and is a professor at Emory University School of Medicine, has claimed that the most significant thing about this drug is that a HIV patient must follow this treatment his or her whole life to make sure is highly effective. Professor Ansari argued that in the first developmental stages of the disease, HIV combats a particular class of immune cells. The purpose of the study is to modify the drug in such a way that it could protect these weak cells. Thus, the immune system will have enough time to mobilize and fight back.

Image source: wikipedia